Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Can Cimetidine, a common antacid, be repurposed for cancer?
A clinical study published in one of the leading oncology journals, Cancer, shows that Cimetidine c
